C ardiac resynchronization therapy (CRT) with biventricular pacing has emerged as a new approach for treating patients with heart failure and significant ventricular conduction delay and/or dyssynchrony. 1-3 CRT improves left ventricular systolic and diastolic function 4 and clinical status 5 and reduces functional mitral regurgitation (MR). 6 Whether CRT significantly affects exercise-induced changes in MR has never been investigated. This study examined the effects of CRT on MR and assessed the determinants of exercise-induced changes in MR under biventricular pacing.• • • This prospective study included 27 consecutive patients with heart failure who were clinically helped by biventricular pacing. Before CRT implantation, all were in New York Heart Association class III and had left ventricular ejection fractions Յ35%, functional MR, were in sinus rhythm, had QRS duration Ն140 ms, and had interventricular delay (the time interval between aortic and pulmonary valve opening) Ն50 ms. All patients underwent quantitative exercise Doppler echocardiography with and without active CRT. The causes of heart failure were idiopathic dilated cardiomyopathy in 9 patients and ischemic heart disease in 18. The protocol was approved by the human ethical committee of our university hospital, and all patients gave informed consent.A symptom-limited graded bicycle exercise test was performed in a semisupine position on a tilting exercise table. After an initial workload of 25 W maintained for 2 minutes, the workload was increased every 2 minutes by 25 W. Blood pressure and 12-lead electrocardiograms were recorded every 2 minutes. Two-dimensional and Doppler echocardiographic recordings were available throughout the test.Baseline and exercise echocardiographic studies were performed 45 Ϯ 16 days after implantation of the CRT system using the phased-array Acuson Sequoia (Siemens AG, Munich, Germany) or VIVID 7 (GE Healthcare, Little Chalfont, United Kingdom) imaging device. In 17 patients, after data acquisition during active CRT (CRT on), pacing was interrupted during 30 minutes before data acquisition during intrinsic conduction (CRT off). In the other 10 patients, data were first acquired with CRT off. All echocardiographic and Doppler recordings were obtained in digital format and stored on optical discs for off-line analysis. For each measurement, Ն3 cardiac cycles were averaged. The quantitation of MR was performed by the quantitative Doppler method using mitral and aortic stroke volumes and the proximal isovelocity surface area method, as previously described. 7,8 The results of these 2 methods were averaged, allowing the calculation of regurgitant volume and the effective regurgitant orifice (ERO). Left ventricular end-diastolic and end-systolic volumes and ejection fractions were measured by the bi-apical Simpson disk method. The left ventricular dP/dt was estimated from the steepest increasing segment of the continuous-
The electrophysiological effects of L 9394 (benzoyl-indolizine), a substance chemically related to amiodarone, but devoid of iodine atoms, were investigated by programmed electrical stimulation of the heart in 12 patients with various forms of tachycardia. Four subjects had electrocardiographic evidence of the WPW syndrome and episodes of circus movement tachycardia. Paroxysmal supraventricular tachycardia, confined to the atrioventricular (AV) node, was found in 3 patients. In 2 cases, where a short PR interval was present, the main complaint was the occurrence of paroxysmal atrial fibrillation. In the remaining 3 instances, the arrhythmia consisted of slow ventricular tachycardia (1 case), supraventricular tachycardia of the focal type (1 case), and episodes of primary ventricular fibrillation, not related to acute myocardial ischaemia (1 case). L 9394 injected intravenously was seen to lengthen the transnodal conduction time as well as the effective and functional refractory periods of the node. Similar effects were found on the retrograde VA pathway. The drug had no action on the infra-Hisian conduction system, on the refractory periods of ventricular muscle, or on the refractory periods of accessory bypasses. The drug was injected during an episode of tachycardia in 6 cases with reproducible supraventricular re-entrant tachycardia. Three had a tachycardia circuit confined to the node. In those instances, the drug had beneficial effects (slowing and interruption of tachycardia, decrease or abolition of echo zone; loss of ability to induce tachycardia). In the other 3 cases, an accessory pathway was incorporated in the circuit. L 9394 interrupted the tachycardia in 2 instances (by anterograde AV block), but failed to protect all 3 patients against reinitiation of tachycardia by premature stimuli. It is concluded that L9394 does not share all the pharmacological properties of amiodarone and will not replace it in all its indications.
BelgiumTwo cases are described in which, during investigation of rhythm disturbances, it was shown that, by delivering atrial stimuli of increasing prematurity, a point was reached where the artificial stimulus failed to induce an atrial response. However, with even more premature stimulations, atrial responses were again observed. These observations are best explained by a gap phenomenon in which very early stimuli delivered during the effective refractory period of the atria were delayed long enough in the exit area around the pacing electrode to allow atrial recovery.The phenomenon of 'gap' in atrioventricular conduction was first described by Moe et al. (1965). During experiments on dogs, they observed a zone in the cardiac cycle when atrial premature beats were not transmitted to the ventricles whereas atrial beats of greater or lesser prematurity were normally conducted to the ventricles. The atrioventricular gap phenomenon occurs when the effective refractory period of a distal site (for example, the His-Purkinje system) is longer than the functional refractory period of a proximal site (for example the AV node), and when closely coupled stimuli are delayed long enough at the proximal site to allow recovery at the distal end (Wu et al., 1974).At present, at least 6 types of gap phenomenon in atrioventricular conduction have been recognised; they differ from one another in the sites of proximal delay and distal block (Damato et al., 1976).In this paper, we report on two patients in whom the electrophysiological findings strongly suggested an unusual gap phenomenon where the exit area around a pacing electrode was the site of proximal delay and the atria the distal site with relatively long effective refractory period. using a bipolar electrode catheter introduced percutaneously into the femoral vein. Two other bipolar electrode catheters were employed, the first to stimulate the high lateral wall of the right atrium and the second to record the high right atrial electrogram.The His bundle electrogram, high right atrial electrogram, and 2 surface leads were recorded simultaneously on a 4-channel Elema Mingograf 81 at a paper speed of 100 mm/s. The stimuli were 2 ms square waves approximately equal to twice diastolic threshold and were delivered using a JS-U2 multipurpose programmable stimulator.During programmed stimulation, the test stimuli were given after each eighth driving stimulus or spontaneous beat, the coupling interval being decreased by decrements of 5 ms. Results CASE 1The patient was a 56-year-old man who had had an acute anterolateral myocardial infarct in September 1975. He was admitted in January 1976 for treatment of cardiac failure with digitalis and diuretics. Investigations at that time showed a large parietal left ventricular aneurysm, a totally occluded left anterior descending artery with poor distal perfusion, and significantly stenosed left circumflex and right coronary arteries. He had recurrent episodes of ventricular tachycardia for which an electrophysiological study was underta...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.